List of Tables
Table 1. Global Carcinoid Tumor Syndrome Treatment Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Carcinoid Tumor Syndrome Treatment Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Carcinoid Tumor Syndrome Treatment Market Competitive Situation by Manufacturers in 2024
Table 4. Global Carcinoid Tumor Syndrome Treatment Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Carcinoid Tumor Syndrome Treatment Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Carcinoid Tumor Syndrome Treatment Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Carcinoid Tumor Syndrome Treatment Average Price (US$/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Carcinoid Tumor Syndrome Treatment, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Product Type & Application
Table 12. Global Key Manufacturers of Carcinoid Tumor Syndrome Treatment, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Carcinoid Tumor Syndrome Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Carcinoid Tumor Syndrome Treatment as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Carcinoid Tumor Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Carcinoid Tumor Syndrome Treatment Sales by Region (2020-2025) & (K Units)
Table 18. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Region (2020-2025)
Table 19. Global Carcinoid Tumor Syndrome Treatment Sales by Region (2026-2031) & (K Units)
Table 20. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Region (2026-2031)
Table 21. Global Carcinoid Tumor Syndrome Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Region (2020-2025)
Table 23. Global Carcinoid Tumor Syndrome Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Region (2026-2031)
Table 25. North America Carcinoid Tumor Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Carcinoid Tumor Syndrome Treatment Sales by Country (2020-2025) & (K Units)
Table 27. North America Carcinoid Tumor Syndrome Treatment Sales by Country (2026-2031) & (K Units)
Table 28. North America Carcinoid Tumor Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Carcinoid Tumor Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Carcinoid Tumor Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Carcinoid Tumor Syndrome Treatment Sales by Country (2020-2025) & (K Units)
Table 32. Europe Carcinoid Tumor Syndrome Treatment Sales by Country (2026-2031) & (K Units)
Table 33. Europe Carcinoid Tumor Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Carcinoid Tumor Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Carcinoid Tumor Syndrome Treatment Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Carcinoid Tumor Syndrome Treatment Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Carcinoid Tumor Syndrome Treatment Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Carcinoid Tumor Syndrome Treatment Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Carcinoid Tumor Syndrome Treatment Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Carcinoid Tumor Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Carcinoid Tumor Syndrome Treatment Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Carcinoid Tumor Syndrome Treatment Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Carcinoid Tumor Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Carcinoid Tumor Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Carcinoid Tumor Syndrome Treatment Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Carcinoid Tumor Syndrome Treatment Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Carcinoid Tumor Syndrome Treatment Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Carcinoid Tumor Syndrome Treatment Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Carcinoid Tumor Syndrome Treatment Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Carcinoid Tumor Syndrome Treatment Sales (K Units) by Type (2020-2025)
Table 51. Global Carcinoid Tumor Syndrome Treatment Sales (K Units) by Type (2026-2031)
Table 52. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Type (2020-2025)
Table 53. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Type (2026-2031)
Table 54. Global Carcinoid Tumor Syndrome Treatment Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Carcinoid Tumor Syndrome Treatment Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Type (2020-2025)
Table 57. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Type (2026-2031)
Table 58. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Type (2020-2025)
Table 59. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Type (2026-2031)
Table 60. Global Carcinoid Tumor Syndrome Treatment Sales (K Units) by Application (2020-2025)
Table 61. Global Carcinoid Tumor Syndrome Treatment Sales (K Units) by Application (2026-2031)
Table 62. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Application (2020-2025)
Table 63. Global Carcinoid Tumor Syndrome Treatment Sales Market Share by Application (2026-2031)
Table 64. Global Carcinoid Tumor Syndrome Treatment Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Carcinoid Tumor Syndrome Treatment Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Application (2020-2025)
Table 67. Global Carcinoid Tumor Syndrome Treatment Revenue Market Share by Application (2026-2031)
Table 68. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Application (2020-2025)
Table 69. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Application (2026-2031)
Table 70. Novartis AG Company Information
Table 71. Novartis AG Description and Business Overview
Table 72. Novartis AG Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 73. Novartis AG Carcinoid Tumor Syndrome Treatment Product
Table 74. Novartis AG Recent Developments/Updates
Table 75. Teva Pharmaceutical Industries Ltd. Company Information
Table 76. Teva Pharmaceutical Industries Ltd. Description and Business Overview
Table 77. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 78. Teva Pharmaceutical Industries Ltd. Carcinoid Tumor Syndrome Treatment Product
Table 79. Teva Pharmaceutical Industries Ltd. Recent Developments/Updates
Table 80. Mylan N.V. Company Information
Table 81. Mylan N.V. Description and Business Overview
Table 82. Mylan N.V. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 83. Mylan N.V. Carcinoid Tumor Syndrome Treatment Product
Table 84. Mylan N.V. Recent Developments/Updates
Table 85. Ipsen Biopharmaceuticals, Inc Company Information
Table 86. Ipsen Biopharmaceuticals, Inc Description and Business Overview
Table 87. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 88. Ipsen Biopharmaceuticals, Inc Carcinoid Tumor Syndrome Treatment Product
Table 89. Ipsen Biopharmaceuticals, Inc Recent Developments/Updates
Table 90. Sun Pharmaceutical Industries Ltd Company Information
Table 91. Sun Pharmaceutical Industries Ltd Description and Business Overview
Table 92. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 93. Sun Pharmaceutical Industries Ltd Carcinoid Tumor Syndrome Treatment Product
Table 94. Sun Pharmaceutical Industries Ltd Recent Developments/Updates
Table 95. Amgen Inc. Company Information
Table 96. Amgen Inc. Description and Business Overview
Table 97. Amgen Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 98. Amgen Inc. Carcinoid Tumor Syndrome Treatment Product
Table 99. Amgen Inc. Recent Developments/Updates
Table 100. Entrinsic Health Solutions, Inc. Company Information
Table 101. Entrinsic Health Solutions, Inc. Description and Business Overview
Table 102. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 103. Entrinsic Health Solutions, Inc. Carcinoid Tumor Syndrome Treatment Product
Table 104. Entrinsic Health Solutions, Inc. Recent Developments/Updates
Table 105. Endo Pharmaceuticals Inc. Company Information
Table 106. Endo Pharmaceuticals Inc. Description and Business Overview
Table 107. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 108. Endo Pharmaceuticals Inc. Carcinoid Tumor Syndrome Treatment Product
Table 109. Endo Pharmaceuticals Inc. Recent Developments/Updates
Table 110. Sirtex SIR-Spheres Pty Ltd Company Information
Table 111. Sirtex SIR-Spheres Pty Ltd Description and Business Overview
Table 112. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 113. Sirtex SIR-Spheres Pty Ltd Carcinoid Tumor Syndrome Treatment Product
Table 114. Sirtex SIR-Spheres Pty Ltd Recent Developments/Updates
Table 115. BTG International Ltd Company Information
Table 116. BTG International Ltd Description and Business Overview
Table 117. BTG International Ltd Carcinoid Tumor Syndrome Treatment Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 118. BTG International Ltd Carcinoid Tumor Syndrome Treatment Product
Table 119. BTG International Ltd Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Carcinoid Tumor Syndrome Treatment Distributors List
Table 123. Carcinoid Tumor Syndrome Treatment Customers List
Table 124. Carcinoid Tumor Syndrome Treatment Market Trends
Table 125. Carcinoid Tumor Syndrome Treatment Market Drivers
Table 126. Carcinoid Tumor Syndrome Treatment Market Challenges
Table 127. Carcinoid Tumor Syndrome Treatment Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 131. Authors List of This Report
List of Figures
Figure 1. Product Picture of Carcinoid Tumor Syndrome Treatment
Figure 2. Global Carcinoid Tumor Syndrome Treatment Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Carcinoid Tumor Syndrome Treatment Market Share by Type: 2024 & 2031
Figure 4. Chemotherapy Product Picture
Figure 5. Biological Therapy Product Picture
Figure 6. Radio Therapy Product Picture
Figure 7. Global Carcinoid Tumor Syndrome Treatment Market Value by Application (2020-2031) & (US$ Million)
Figure 8. Global Carcinoid Tumor Syndrome Treatment Market Share by Application: 2024 & 2031
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Home
Figure 12. Global Carcinoid Tumor Syndrome Treatment Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Carcinoid Tumor Syndrome Treatment Market Size (2020-2031) & (US$ Million)
Figure 14. Global Carcinoid Tumor Syndrome Treatment Sales (2020-2031) & (K Units)
Figure 15. Global Carcinoid Tumor Syndrome Treatment Average Price (US$/Unit) & (2020-2031)
Figure 16. Carcinoid Tumor Syndrome Treatment Report Years Considered
Figure 17. Carcinoid Tumor Syndrome Treatment Sales Share by Manufacturers in 2024
Figure 18. Global Carcinoid Tumor Syndrome Treatment Revenue Share by Manufacturers in 2024
Figure 19. Global 5 and 10 Largest Carcinoid Tumor Syndrome Treatment Players: Market Share by Revenue in Carcinoid Tumor Syndrome Treatment in 2024
Figure 20. Carcinoid Tumor Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 21. Global Carcinoid Tumor Syndrome Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 22. North America Carcinoid Tumor Syndrome Treatment Sales Market Share by Country (2020-2031)
Figure 23. North America Carcinoid Tumor Syndrome Treatment Revenue Market Share by Country (2020-2031)
Figure 24. United States Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 25. Canada Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. Europe Carcinoid Tumor Syndrome Treatment Sales Market Share by Country (2020-2031)
Figure 27. Europe Carcinoid Tumor Syndrome Treatment Revenue Market Share by Country (2020-2031)
Figure 28. Germany Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. France Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. U.K. Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 31. Italy Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 32. Russia Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Asia Pacific Carcinoid Tumor Syndrome Treatment Sales Market Share by Region (2020-2031)
Figure 34. Asia Pacific Carcinoid Tumor Syndrome Treatment Revenue Market Share by Region (2020-2031)
Figure 35. China Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Japan Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. South Korea Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. India Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Australia Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. China Taiwan Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Southeast Asia Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 42. Latin America Carcinoid Tumor Syndrome Treatment Sales Market Share by Country (2020-2031)
Figure 43. Latin America Carcinoid Tumor Syndrome Treatment Revenue Market Share by Country (2020-2031)
Figure 44. Mexico Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Brazil Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Argentina Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 47. Middle East and Africa Carcinoid Tumor Syndrome Treatment Sales Market Share by Country (2020-2031)
Figure 48. Middle East and Africa Carcinoid Tumor Syndrome Treatment Revenue Market Share by Country (2020-2031)
Figure 49. Turkey Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. UAE Carcinoid Tumor Syndrome Treatment Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 52. Global Sales Market Share of Carcinoid Tumor Syndrome Treatment by Type (2020-2031)
Figure 53. Global Revenue Market Share of Carcinoid Tumor Syndrome Treatment by Type (2020-2031)
Figure 54. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Type (2020-2031)
Figure 55. Global Sales Market Share of Carcinoid Tumor Syndrome Treatment by Application (2020-2031)
Figure 56. Global Revenue Market Share of Carcinoid Tumor Syndrome Treatment by Application (2020-2031)
Figure 57. Global Carcinoid Tumor Syndrome Treatment Price (US$/Unit) by Application (2020-2031)
Figure 58. Carcinoid Tumor Syndrome Treatment Value Chain
Figure 59. Channels of Distribution (Direct Vs Distribution)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
